
Bitcoin: A Lifeline for Biotech Firms Amidst Industry Challenges | 2025
Credit: Image by Yahoo via YAHOO NEWS Bitcoin: A Lifeline for Biotech Firms Amidst Industry Challenges In a recent statement, Christian Angermayer, the founder of Atai Life Sciences, highlighted the potential of Bitcoin as a crucial asset for biotech companies striving to endure the prolonged and arduous drug approval process. With the biopharmaceutical landscape facing…